At least three issues affecting pharmacy compounding might be affected by the overturning of the...
What’s happened in the world of federal regulation since the Supreme Court overturned the decades-old Chevron doctrine in its Loper Bright decision? FDA Law Blog takes a look in “As Jurisprudence Under Loper Bright Develops, Early Scorecard is Mixed.”
At least three issues affecting pharmacy compounding might be affected by the overturning of the...
Recognize the guy on the cover of NCPA's America's Pharmacist December magazine? Of course not —...
Going to Informa Connect’s Compounding Pharmacy Compliance Year-End Update in December in Philly?...